SAS PROC GLM with group effect [General Sta­tis­tics]

posted by d_labes  – Berlin, Germany, 2014-05-22 16:11 (4066 d 01:05 ago) – Posting: # 12988
Views: 15,546

Dear Silva,

Using your code:BTW: The link in my post below (FDA suggestion to deal with group effects) the model statement became more involved:
model lnCmax = group sequence form subject(group*sequence) period(group)
               group*sequence group*form;

Not quite clear which denominator has to be choosen for all that terms.

Hope this helps.

@Helmut: This thread has nothing to to with Regulatives/Guidelines I think. You may consider shifting it.

Done. [Helmut]

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,688 registered users;
62 visitors (0 registered, 62 guests [including 17 identified bots]).
Forum time: 17:17 CEST (Europe/Vienna)

If I’d observed all the rules,
I’d never have got anywhere.    Marilyn Monroe

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5